医学
重症监护医学
重症监护室
抗生素
小心等待
重症监护
人口
梅德林
检测点注意事项
作者
Kerina J. Denny,J. De Wale,Kevin B. Laupland,Patrick N A Harris,Jeffrey Lipman
标识
DOI:10.1016/j.cmi.2019.07.007
摘要
ABSTRACT
Background
Most intensive care unit (ICU) patients receive broad-spectrum antibiotics. While lifesaving in some, in others these treatments may be unnecessary and place patients at risk of antibiotic-associated harms. Objectives
To review the literature exploring how we diagnose infection in patients in the ICU and address the safety and utility of a ‘watchful waiting' approach to antibiotic initiation with selected patients in the ICU. Sources
A semi-structured search of PubMed and Cochrane Library databases for articles published in English during the past 15 years was conducted. Content
Distinguishing infection from non-infectious mimics in ICU patients is uniquely challenging. At present, we do not have access to a rapid point-of-care test that reliably differentiates between individuals who need antibiotics and those who do not. A small number of studies have attempted to compare early aggressive versus conservative antimicrobial strategies in the ICU. However, this body of literature is small and not robust enough to guide practice. Implications
This issue will not likely be resolved until there are diagnostic tests that rapidly and reliably identify the presence or absence of infection in the ICU population. In the meantime, prospective trials that identify clinical situations wherein it is safe to delay or withhold antibiotic initiation in the ICU until the presence of an infection is proven are warranted.
科研通智能强力驱动
Strongly Powered by AbleSci AI